PROFILO, MARIA ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 601
EU - Europa 320
AS - Asia 74
AF - Africa 23
SA - Sud America 2
OC - Oceania 1
Totale 1.021
Nazione #
US - Stati Uniti d'America 587
SE - Svezia 112
IT - Italia 70
CN - Cina 41
DE - Germania 39
BG - Bulgaria 30
GB - Regno Unito 23
FR - Francia 17
CI - Costa d'Avorio 15
CA - Canada 13
AT - Austria 12
VN - Vietnam 12
SG - Singapore 7
SN - Senegal 7
IN - India 6
UA - Ucraina 6
FI - Finlandia 5
HK - Hong Kong 5
RU - Federazione Russa 5
TR - Turchia 2
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
JP - Giappone 1
MA - Marocco 1
PA - Panama 1
Totale 1.021
Città #
Houston 88
Ann Arbor 69
Fairfield 69
Woodbridge 62
Seattle 50
Chandler 48
Ashburn 41
Serra 38
Sofia 30
Cambridge 28
Wilmington 26
Abidjan 15
New York 14
Beijing 12
Ottawa 12
Vienna 12
London 11
Princeton 10
Bremen 9
Florence 9
Lawrence 9
Dearborn 8
Nanjing 8
Dakar 7
Des Moines 7
Lancaster 7
Marseille 7
Medford 7
Dong Ket 6
Aosta 5
Hong Kong 4
Kunming 4
Munich 4
Nanchang 4
Frankfurt am Main 3
Hefei 3
Jüchen 3
Manchester 3
Da Nang 2
Englewood 2
Hebei 2
Izmir 2
Jacksonville 2
Ogden 2
Redwood City 2
San Diego 2
San Francisco 2
Brussels 1
Changsha 1
Chengdu 1
Chicago 1
Düsseldorf 1
Fuzhou 1
Grafing 1
Highland 1
Jinan 1
Lanzhou 1
Melbourne 1
Ningbo 1
Palm City 1
Panama City 1
Pune 1
Rome 1
Santiago 1
Shenyang 1
Tianjin 1
Toronto 1
Totale 790
Nome #
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 146
null 121
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 111
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 109
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 108
null 97
null 91
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 91
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study 69
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 64
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 25
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 19
Totale 1.051
Categoria #
all - tutte 2.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201956 0 0 0 0 0 0 0 0 0 0 27 29
2019/2020260 31 18 33 17 24 32 24 18 21 13 24 5
2020/202188 9 5 4 3 16 1 7 5 12 8 7 11
2021/2022156 1 3 0 11 34 14 2 4 37 14 1 35
2022/2023198 23 44 17 15 14 16 2 12 42 0 11 2
2023/202455 2 5 8 0 10 15 0 11 2 2 0 0
Totale 1.051